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Our experience in the treatment of over 20,000 atopic
eczema, urticaria and psoriasis patients shows that
besides allergic reactions to foods an increasing number
of pseudoallergic reactions caused by toxic-irritative pol-
lutants (formaldehyde, exhaust particles, additive-rich
food, nicotine, wood preservatives, pesticides, heavy
metals) are responsible for the inflammatory process
behind the complex symptoms. Intrauterine and postna-
tal environmental influences were also reported. The
routine analysis of specific IgE- and IgG4-factors in our
atopic patients by means of ELISA-assays after challenge
meals (CM) showed an increased frequency of specific
IgE- and IgG4-antibodies after repeated CM. In 60% of
the patients, we simultaneously found raised concentra-
tions of the IgE- and IgG-CIC (p< 0.005) responsible for
the delayed allergic reactions in the same group. Further
inflammation markers like acute phase proteins (a1–
antitrypsin, a2–makroglobulin, haptoglobin and caerulo-
plasmin) showed a surprisingly rapid increase after CM
(p< 0.01) in the atopic group; by contrast the control
samples remained in the normal range. Serum histamine
levels (RIA-Test) also showed a significant increase 1/2
hour after CM and after individual oral provocation with
lactose, sucrose, tyramine, serotonine or phenylethylamine,
respectively. The carbohydrate intolerance reactions (H2-
test) were in good correlation to the significantly lowered
disaccharidase activites (lactase, sucrase) in the gut of ato-
pic eczema patients (p< 0.001). This was closely related to
chronic intestinal dysbiosis with toxic microbial break-
down products (alcohols, aldehydes, phenols, diamines)
leading to an increased intestinal permeability, histamine
release and impairment of liver detox functions. On the
other side, we found both in atopic eczema and in psoria-
sis patients pseudoallergic reactions against biogenic
amines and constantly raised serum histamine levels (also
in fasted patients), suggesting an inhibition of catabolic
enzymes (MAO, DAO, NMT). Previously published
results from our laboratory showed significantly reduced
DAO (p< 0.001) and Type B MAO- (p< 0.05) activities in
thrombocyte-rich plasma of atopic eczema and psoriasis
patients explaining their intolerance reactions to hista-
mine, tyramine and octopamine rich foods. Last, but not
least, the chronic increased levels of free radicals in whole
blood and plasma of all patient groups showed significant
changes after oral intake of different food homogenates/
juices dependent on their ROS-blocking or ROS-increas-
ing effects (enhanced chemoluminescence test). Our cur-
rent research shows that appropriate combinations of
hypoallergenic protein hydrolysates with particular sugar
alcohols and omega-3 fatty acids (EQUIDERM PLUS®)
are dramatically enhancing the anti-inflammatory and free
radical quenching properties of the mixture, demonstrat-
ing an excellent compliance and therapy efficiency in ato-
pic, psoriasis and geriatric patients. With the emergence of
affordable microarray gene expression profiling methods,
the opportunity arises to ex-vivo test certain combinations
for their silencing ability on inflammatory genes before
administering the nutraceutical to the patient (nutrige-
nomic evaluation). The input of the above mentioned
nutritional data in a computer supported, individual rota-
tion diet plan (FOOD ALLERGY CONTROL®) ensures a
gradual improvement of the symptoms and stabilization of
the clinical course during and after therapy.
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